You just read:

Alopexx Oncology Presents Encouraging Phase I/II Clinical Data On DI-Leu16-IL2 At The American Society Of Hematology Annual Meeting

News provided by

Alopexx Oncology, LLC

Dec 07, 2015, 07:00 ET